Clinical Trials Logo

Clinical Trial Summary

RATIONALE: Modern radiotherapy techniques in a neoadjuvant setting have the potential to minimize morbidity and maximize efficacy. An additional boost dose can be provided locally by HDR-brachytherapy in patients with positive margins after tumor resection.

PURPOSE: This phase II trial is studying the safety and efficacy of a combination of modern radiotherapy elements applied to the tumor and small volumes of surrounding normal tissue (IMRT, IGRT; brachytherapy in case of positive resection margin) and see how well it works in treating patients with High-Risk Soft Tissue Sarcoma of the Extremities.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01552239
Study type Interventional
Source Technische Universität München
Contact Barbara Röper, MD
Phone +49-89-4140
Email barbara.roeper@lrz.tu-muenchen.de
Status Recruiting
Phase Phase 2
Start date August 2011
Completion date October 2019